Annette Dieing

1.6k total citations
27 papers, 354 citations indexed

About

Annette Dieing is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Annette Dieing has authored 27 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 9 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in Annette Dieing's work include Testicular diseases and treatments (11 papers), Cancer Treatment and Pharmacology (6 papers) and Thermal Regulation in Medicine (4 papers). Annette Dieing is often cited by papers focused on Testicular diseases and treatments (11 papers), Cancer Treatment and Pharmacology (6 papers) and Thermal Regulation in Medicine (4 papers). Annette Dieing collaborates with scholars based in Germany, Switzerland and United States. Annette Dieing's co-authors include Thoralf Kerner, Bert Hildebrandt, Peter Wust, Olaf Ahlers, Anja Lorch, Carsten Bokemeyer, Bernd Flath, Carsten‐Oliver Schulz, Peter Schmid and Kurt Possinger and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Lancet Oncology.

In The Last Decade

Annette Dieing

25 papers receiving 346 citations

Peers

Annette Dieing
J. Collin United Kingdom
Canan Tanık Türkiye
M Shirasu Japan
Kui Meng China
Yi Kyeong Chun South Korea
J. Collin United Kingdom
Annette Dieing
Citations per year, relative to Annette Dieing Annette Dieing (= 1×) peers J. Collin

Countries citing papers authored by Annette Dieing

Since Specialization
Citations

This map shows the geographic impact of Annette Dieing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annette Dieing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annette Dieing more than expected).

Fields of papers citing papers by Annette Dieing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annette Dieing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annette Dieing. The network helps show where Annette Dieing may publish in the future.

Co-authorship network of co-authors of Annette Dieing

This figure shows the co-authorship network connecting the top 25 collaborators of Annette Dieing. A scholar is included among the top collaborators of Annette Dieing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annette Dieing. Annette Dieing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Papachristofilou, Alexandros, Jens Bedke, Stefanie Hayoz, et al.. (2022). Single-dose carboplatin followed by involved-node radiotherapy for stage IIA and stage IIB seminoma (SAKK 01/10): a single-arm, multicentre, phase 2 trial. The Lancet Oncology. 23(11). 1441–1450. 19 indexed citations
3.
Hentrich, Marcus, Mark Bower, Gedske Daugaard, et al.. (2021). Outcomes of men with HIV and germ cell cancer: Results from an international collaborative study. Cancer. 128(2). 260–268. 2 indexed citations
4.
Heinzelbecker, Julia, Stefanie Schmidt, Jonas Busch, et al.. (2021). Therapy of clinical stage IIA and IIB seminoma: a systematic review. World Journal of Urology. 40(12). 2829–2841. 9 indexed citations
5.
Oing, Christoph, Marcus Hentrich, Anja Lorch, et al.. (2019). Treatment of refractory germ-cell tumours with single-agent cabazitaxel: a German Testicular Cancer Study Group case series. Journal of Cancer Research and Clinical Oncology. 146(2). 449–455. 8 indexed citations
6.
Fenner, Martin, Christoph Oing, Annette Dieing, et al.. (2018). Everolimus in patients with multiply relapsed or cisplatin refractory germ cell tumors: results of a phase II, single-arm, open-label multicenter trial (RADIT) of the German Testicular Cancer Study Group. Journal of Cancer Research and Clinical Oncology. 145(3). 717–723. 26 indexed citations
7.
Seidel, Christoph, Karin Oechsle, Anja Lorch, et al.. (2015). Efficacy and safety of gemcitabine, oxaliplatin, and paclitaxel in cisplatin-refractory germ cell cancer in routine care—Registry data from an outcomes research project of the German Testicular Cancer Study Group. Urologic Oncology Seminars and Original Investigations. 34(4). 168.e21–168.e28. 25 indexed citations
8.
Regierer, Anne C., et al.. (2011). 5FU Continuous Infusion in Heavily Pretreated Advanced Breast Cancer Patients. Onkologie. 34(12). 696–700. 1 indexed citations
9.
Lorch, Anja, Andreas Neubauer, Annette Dieing, et al.. (2009). High-dose chemotherapy (HDCT) as second-salvage treatment in patients with multiple relapsed or refractory germ-cell tumors. Annals of Oncology. 21(4). 820–825. 42 indexed citations
10.
Regierer, Anne C., Andrea Stroux, Annette Dieing, et al.. (2008). Contrast-Enhancing Meningeal Lesions Are Associated with Longer Survival in Breast Cancer-Related Leptomeningeal Metastasis. Breast Care. 3(2). 118–123. 8 indexed citations
11.
Dieing, Annette, Olaf Ahlers, Bert Hildebrandt, et al.. (2007). The effect of induced hyperthermia on the immune system. Progress in brain research. 162. 137–152. 35 indexed citations
12.
Schmid, Peter, V. Heilmann, Carsten‐Oliver Schulz, et al.. (2005). Gemcitabine as prolonged infusion and vinorelbine in anthracycline and/or taxane pretreated metastatic breast cancer: a phase II study. Journal of Cancer Research and Clinical Oncology. 131(9). 568–574. 12 indexed citations
13.
14.
Ahlers, Olaf, Bert Hildebrandt, Annette Dieing, et al.. (2005). Stress induced changes in lymphocyte subpopulations and associated cytokines during whole body hyperthermia of 41.8–42.2°C. European Journal of Applied Physiology. 95(4). 298–306. 30 indexed citations
15.
Dieing, Annette, et al.. (2005). Benefit of cytostatic therapy in 3rd and following line in metastatic breast cancer. Journal of Clinical Oncology. 23(16_suppl). 742–742. 1 indexed citations
16.
Dieing, Annette, Carsten‐Oliver Schulz, Peter Schmid, et al.. (2004). Orbital metastases in breast cancer: report of two cases and review of the literature. Journal of Cancer Research and Clinical Oncology. 130(12). 745–748. 40 indexed citations
17.
Schmid, Peter, Carsten‐Oliver Schulz, Annette Dieing, et al.. (2004). Primary chemotherapy with gemcitabine, liposomal doxorubicin and docetaxel in patients with locally advanced breast cancer: results of a phase I trial. Anti-Cancer Drugs. 16(1). 21–29. 14 indexed citations
18.
Dieing, Annette, Olaf Ahlers, Thoralf Kerner, et al.. (2003). Whole body hyperthermia induces apoptosis in subpopulations of blood lymphocytes. Immunobiology. 207(4). 265–273. 27 indexed citations
19.
Kerner, Thoralf, Maria Deja, Olaf Ahlers, et al.. (2002). Monitoring arterial blood pressure during whole body hyperthermia. Acta Anaesthesiologica Scandinavica. 46(5). 561–566. 8 indexed citations
20.
Hildebrandt, Bert, Peter Wust, Oliver Rick, et al.. (2001). Ganzkörperhyperthermie bei Keimzellentumoren. Der Onkologe. 7(3). 324–330. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026